web statistics
KineMed  ► 
Our unique window into living biology is revolutionizing pharma R&D programs and generating comprehensive drug-diagnostic solutions for improved disease management
Find out more


Latest News

KineMed Announces Participation in a Global, Multi-Company Effort t...
KineMed Announces Participation in a Global, Multi-Company Effort to Advance and Standardize a Diabetic Research Model
4/21/2014 1:00:00 AM

KineMed, Inc. announced participation in a global, two year, multi-organization effort to advance and standardize a single mouse model of early diabetic disease detection and progression. The two year effort brings together cutting edge expertise and technology with a goal to produce a new mouse research model system that can streamline the research and development of advances in diabetic research and improve the clinical success of programs using the model.

Default news teaser image
KineMed to Present Platform for Metabolic Biomarker Discovery at the American Association for Cancer Research Annual Meeting
4/4/2014 1:00:00 AM

KineMed, Inc. announced today that Dr. Marc Hellerstein, KineMed’s President and CSO, will give an invited presentation titled “Quantifying in vivo metabolic pathway fluxes and network dynamics using heavy water and  mass spectrometry: A new class of disease biomarkers” at the American Association for Cancer Research Annual Meeting, taking place April 5-9, in San Diego, California.

KineMed to Present Data on Fibrosis Biomarkers at the Keystone Fibr...
KineMed to Present Data on Fibrosis Biomarkers at the Keystone Fibrosis Symposium
3/20/2014 1:00:00 AM

KineMed, Inc. announced today that abstracts were accepted for three oral and four poster presentations highlighting its work in liver fibrosis at the Keystone Fibrosis Symposium taking place March 23–28, 2014 in Keystone, Colorado. Dr. Scott Turner, KineMed’s Executive Vice President of Research, Dr. Claire Emson, KineMed’s Director of Fibrosis Research, and Dr. Martin Decaris, postdoctoral researcher in Cellular and Molecular Kinetics at KineMed, will represent KineMed at the conference.

Technology Highlight Video

Marc Hellerstein, M.D., Ph.D., President and Chief Scientific Officer talks about the power of Proteome Dynamics at the Personalized Medicine World Conference 
Bookmark this page to: Add to Delicious  Add to LinkedIn  Add to Digg  Add to Reddit  Add to Yahoo Bookmarks  Add to Twitter  Add to Facebook  Add to StumbleUpon  Add to Google Bookmarks

5980 Horton Street | Suite 470 | Emeryville, CA 94608 | Tel.: USA [1] 510.655.6525 | Fax: [1] 510.655.6506 | TOLL-FREE: 855.KINEMED | E-mail: info@kinemed.com

 Copyright © 2013 KineMed, Inc.  |  All Rights Reserved  |  Privacy  |  Terms & Conditions